Exact Sciences Corporation (EXAS - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 16.3% in the past one-month time frame.
The move came after the company delivered yet another quarter of greater than 100% top-line growth.
The company has seen one positive estimate revision in the past four weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the same time frame, suggesting that more solid trading could be ahead for Exact Sciences. So make sure to keep an eye on this stock going forward to see if this recent jump can turn
Exact Sciences currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Exact Sciences Corporation Price and Consensus
Another stock worth considering in the Medical - Biomedical and Genetics industry is Agenus Inc.(AGEN - Free Report) which carries a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.
Is EXAS going up? Or down? Predict to see what others think: Up or Down
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artifical intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>